The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae andStaphylococcus aureusin European hospitals, 2010 and 2011: a multicentre retrospective cohort study

Economic burden of antibiotic resistance: how much do we really know?

(2014) S. Gandra et al.   CLINICAL MICROBIOLOGY AND INFECTION

Valuation of Hospital Bed-Days Released by Infection Control Programs: A Comparison of Methods

(2014) Andrew J. Stewardson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Incidence in ICU populations: how to measure and report it?

(2014) Jan Beyersmann et al.   INTENSIVE CARE MEDICINE

Long-term consequences of severe infections

(2013) L. Leibovici   CLINICAL MICROBIOLOGY AND INFECTION

Trends in Human Fecal Carriage of Extended-Spectrum  -Lactamases in the Community: Toward the Globalization of CTX-M

(2013) P.-L. Woerther et al.   CLINICAL MICROBIOLOGY REVIEWS

Antibiotic resistance—the need for global solutions

(2013) Ramanan Laxminarayan et al.   LANCET INFECTIOUS DISEASES

The true cost of antimicrobial resistance

(2013) R. Smith et al.   BMJ-British Medical Journal

Secular Trends in Nosocomial Bloodstream Infections: Antibiotic-Resistant Bacteria Increase the Total Burden of Infection

(2012) H. S. M. Ammerlaan et al.   CLINICAL INFECTIOUS DISEASES

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System

(2012) M.E.A. de Kraker et al.   CLINICAL MICROBIOLOGY AND INFECTION

Burden of Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae Determined Using Multistate Modeling at a Swiss University Hospital and a Nationwide Predictive Model

(2012) Andrew Stewardson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

(2012) Wouter C. Rottier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-ResistantStaphylococcus aureusBloodstream Infections

(2011) Marlieke E. A. de Kraker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Application of multistate models in hospital epidemiology: Advances and challenges

(2011) Jan Beyersmann et al.   BIOMETRICAL JOURNAL

Estimating the Cost of Health Care–Associated Infections: Mind Your p’s and q’s

(2010) Nicholas Graves et al.   CLINICAL INFECTIOUS DISEASES

Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins

(2010) M. E. A. de Kraker et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study

(2010) Marie-Laurence Lambert et al.   LANCET INFECTIOUS DISEASES

Pseudo-observations in survival analysis

(2009) Per Kragh Andersen et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Transmission-associated nosocomial infections: Prolongation of intensive care unit stay and risk factor analysis using multistate models

(2008) Jan Beyersmann et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings: SHEA/HICPAC Position Paper

(2008) Adam L. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY